Efficacy of radionuclide treatment DOTATATE Y-90 in patients with progressive metastatic gastroenteropancreatic neuroendocrine carcinomas (GEP-NETs): a phase II study
Titel:
Efficacy of radionuclide treatment DOTATATE Y-90 in patients with progressive metastatic gastroenteropancreatic neuroendocrine carcinomas (GEP-NETs): a phase II study
Auteur:
Cwikla, J.B. Sankowski, A. Seklecka, N. Buscombe, J.R. Nasierowska-Guttmejer, A. Jeziorski, K.G. Mikolajczak, R. Pawlak, D. Stepien, K. Walecki, J.